Search for a rare disease
Other search option(s)
Fetal trimethadione syndrome
Disease definition
Fetal trimethadione syndrome is a drug-related embryofetopathy that can occur when an embryo/fetus is exposed to trimethadione and that is characterized by pre- and post-natal growth retardation, intellectual deficit, developmental and speech delay, craniofacial anomalies (with some similarities to those seen in fetal valproate syndrome; see this term), and less commonly, cleft palate, malformations of the heart, urogenital system and limbs. Trimethadione is an antiepileptic drug that has been removed from the market in Europe and is no longer used much in other countries due to teratogenicity and potential side effects.
ORPHA:1913
- Synonym(s): -
- Prevalence: Unknown
- Inheritance: Not applicable
- Age of onset: Antenatal, Neonatal
- ICD-10: Q86.8
- OMIM: -
- UMLS: C0265373
- MeSH: C537798
- GARD: -
- MedDRA: -
Additional information
Further information on this disease
Health care resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.